La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Antipsychotic Agents (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antipsychotic Agents (pharmacology) < Antipsychotic Agents (therapeutic use) < Anxiety  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000004 (????) F. Tison [France] ; J. Lecaroz ; L. Letenneur ; J F DartiguesParkinsonism and exposure to neuroleptic drugs in elderly people living in institutions.
000244 (2002) Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
000449 (????) V. Mesnage [France] ; J L Houeto ; A M Bonnet ; I. Clavier ; I. Arnulf ; F. Cattelin ; G. Le Fur ; P. Damier ; M L Welter ; Yves AgidNeurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease.
000536 (????) C. Ricard [France] ; K. Martin ; M. Tournier ; B. Bégaud ; H. Verdoux[A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder].
000877 (2008) M-A Crocq [France] ; V. Camus ; B. Millet ; J. Gliskman ; J-M Azorin ; M-O Krebs ; F. Limosin ; J. Costentin ; J. Daléry[Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].
000F89 (2012) Alexandra Foubert-Samier [France] ; Catherine Helmer ; Florian Perez ; Mélanie Le Goff ; Sophie Auriacombe ; Alexis Elbaz ; Jean-François Dartigues ; François TisonPast exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort.
001278 (2014) L. Gaboriau [France] ; C. Victorri-Vigneau [France] ; M. Gérardin [France] ; G. Allain-Veyrac [France] ; P. Jolliet-Evin [France] ; M. Grall-Bronnec [France]Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports.
001533 (2014) H. Verdoux [France] ; E. PambrunClozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample.
001E38 (1996) P. Auzou [France] ; C. Ozsancak ; D. Hannequin ; N. Moore ; P. AugustinClozapine for the treatment of psychosis in Parkinson's disease: a review.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antipsychotic Agents (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antipsychotic Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antipsychotic Agents (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024